On becoming 65 in Ontario. Effects of drug plan eligibility on use of prescription medicines
Grootendorst PV, O'Brien BJ, Anderson GM. Med Care. 1997; 35(4):386-98.
Publications
Socio-economic status and visits to physicians by adults in Ontario, Canada
McIsaac W, Goel V, Naylor D. J Health Serv Res Policy. 1997; 2(2):94-102.
Cancer Surgery in Ontario
Case selection and appropriateness of coronary angiography and coronary artery bypass graft surgery in British Columbia and Ontario
Anderson GM, Pinfold SP, Hux JE, Naylor CD. Can J Cardiol. 1997;13(3):246-52.
The rise of tamoxifen: temporal and geographical trends of tamoxifen use in Ontario
Palda VA, Goel V, Sawka CA. Breast Cancer Res Treat. 1997; 43(1):33-41.
Physicians’ opinions about decision aids for patients considering systemic adjuvant therapy for axillary-node negative breast cancer
O'Connor AM, Llewellyn-Thomas HA, Sawka C, Pinfold SP, To T, Harrison DE. Patient Educ Couns. 1997; 30(2):143-53.
Spirometry utilization in Ontario: patterns of practice and policy implications
Chan B, Anderson G, Dales RE. CMAJ. 1997; 156(2):169–176.
Patterns of initial management of node-negative breast cancer in two Canadian provinces
Goel V, Olivotto I, Hislop TG, Sawka C, Coldman A, Holowaty EJ. CMAJ. 1997; 156(1):25-35.
Development of an instrument to measure cancer screening knowledge, attitudes and behaviours
Kindree T, Ashbury FD, Goel V, Levy I, Lipskie T, Futcher R. Chronic Dis Can. 1997; 18(4):168-75.
Compliance with practice guidelines for node-negative breast cancer
Olivotto IA, Coldman AJ, Hislop TG, Trevisan CH, Kula J, Goel V, Sawka C. J Clin Oncol. 1997; 15(1):216-22.